Back to News
Market Impact: 0.25

Wall Street Analysts See a 100.71% Upside in Enovis (ENOV): Can the Stock Really Move This High?

Analyst EstimatesAnalyst InsightsCompany FundamentalsCorporate EarningsInvestor Sentiment & PositioningHealthcare & Biotech

Consensus price target implies a 100.7% upside for Enovis (ENOV). The article cautions that price-target-based signals are often unreliable, but notes an upward trend in earnings estimate revisions that could support near-term upside for the stock.

Analysis

Consensus price target implies a 100.7% upside for Enovis (ENOV). The article cautions that price-target-based signals are often unreliable, but notes an upward trend in earnings estimate revisions that could support near-term upside for the stock.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.15